Daily Archives: September 17, 2014

Global Corporate Challenge(C) Names Alcoa “World’s Most Active Organization” for Second Year Running

NEW YORK, September 17, 2014 /PRNewswire/ — Alcoa employees have taken home the title of “World’s Most Active Organization” for the second consecutive year. In teams of seven, the workforce…

Quality Exams at Your Fingertips

— Mindray Releases New Generation DC-70 Ultrasound System SHENZHEN, China, September 17, 2014 /PRNewswire/ — Mindray (NYSE:MR)announced its new generation DC-70 ultrasound System has been officially released worldwide. The system…

New Wearable Technologies Conference in Taipei Helps Manufacturers Build Regulatory Knowledge Foundation

TAIPEI, Sept. 17, 2014 /PRNewswire/ — UL (Underwriters Laboratories), a global safety science leader, announced today it will host a conference on Wearable Technologies featuring product testing and certification in…

“Saint”, a Collaborative Range of AM Eyewear and World Renowned Fashion Photographer Pierre Toussaint, with Support from ZEISS

SYDNEY, Sept. 17, 2014 /PRNewswire/ — The SAINT collaboration between Pierre Toussaint and AM Eyewear transpired out of a shared desire for superior optics. As a leading fashion photographer, Pierre understands the…

3SBio Inc. obtains exclusive licenses to develop and market JenKem’s PEG-Irinotecan in China

— PEG-Irinotecan is a novel, long-acting polymer-drug conjugate which inhibits Topo-I associated with solid tumors — 3SBio Inc. intends to initially develop PEG-irinotecan for metastatic breast cancer and colorectal cancer…

Chindex Stockholders Approve Merger

BETHESDA, Md., September 17, 2014 /PRNewswire/ — Chindex International, Inc. (“Chindex” or the “Company”) (Nasdaq: CHDX) announced that, at a special meeting of stockholders held today, the Company’s stockholders adopted…

Denovo Biopharma Acquires Late-Stage Oncology Drug From lilly For Development As A Personalized Medicine

SAN DIEGO, Sept. 17, 2014 /PRNewswire/ — Denovo Biopharma, LLC, today announced that it has acquired enzastaurin, a late-stage oncology drug, from Eli Lilly and Company (NYSE: LLY). Denovo gains all rights…